1 |
Rauff B, Alzahrani B, Chudhary SA, Nasir B, Mahmood S, Bhinder MA, Faheem M, Amar A. PNPLA3 and TM6SF2 genetic variants and hepatic fibrosis and cirrhosis in Pakistani chronic hepatitis C patients: a genetic association study. BMC Gastroenterol 2022;22:401. [PMID: 36028802 DOI: 10.1186/s12876-022-02469-6] [Reference Citation Analysis]
|
2 |
Pyo JY, Ahn SS, Lee LE, Choi GM, Song JJ, Park YB, Lee SW. The novel fibrosis index at diagnosis may predict all-cause mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis without substantial liver diseases. Clinics (Sao Paulo) 2021;76:e2501. [PMID: 33852653 DOI: 10.6061/clinics/2021/e2501] [Reference Citation Analysis]
|
3 |
Rauff B, Amar A, Chudhary SA, Mahmood S, Tayyab GUN, Hanif R. Interferon-λ rs12979860 genotype association with liver fibrosis in chronic hepatitis C (CHC) patients in the Pakistani population. Arch Virol 2021;166:1047-56. [PMID: 33528661 DOI: 10.1007/s00705-020-04901-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
4 |
Zirnis AE, Straume Z, Bērziņa R, Māliņa-bambīte J, Derovs A, Zeltiņa I. Establishing Cut-Offs for Non-Invasive Liver Tests to Detect Cirrhosis at a High Sensitivity. Proceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences. 2020;74:118-124. [DOI: 10.2478/prolas-2020-0019] [Reference Citation Analysis]
|